Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors.


Journal

Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750

Informations de publication

Date de publication:
08 2023
Historique:
revised: 29 05 2023
received: 01 02 2023
accepted: 21 06 2023
pmc-release: 01 08 2024
medline: 31 7 2023
pubmed: 24 6 2023
entrez: 24 6 2023
Statut: ppublish

Résumé

Antiviral therapeutics to treat SARS-CoV-2 are needed to diminish the morbidity of the ongoing COVID-19 pandemic. A well-precedented drug target is the main viral protease (M

Identifiants

pubmed: 37354015
doi: 10.1002/pro.4712
pmc: PMC10364469
doi:

Substances chimiques

3C-like proteinase, SARS-CoV-2 EC 3.4.22.-
Protease Inhibitors 0
Viral Nonstructural Proteins 0
Antiviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4712

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM145460
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI163912
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM122481
Pays : United States
Organisme : NIH HHS
ID : R35GM122481
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI171110
Pays : United States
Organisme : NIH HHS
ID : R21AI163912
Pays : United States
Organisme : NIAID NIH HHS
ID : U19AI135972
Pays : United States
Organisme : NIAID NIH HHS
ID : U19AI171110
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135972
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93021C00014
Pays : United States

Informations de copyright

© 2023 The Protein Society.

Références

J Med Chem. 2020 Nov 12;63(21):12725-12747
pubmed: 33054210
Infect Disord Drug Targets. 2006 Mar;6(1):3-16
pubmed: 16787300
Nat Rev Drug Discov. 2022 Dec;21(12):881-898
pubmed: 36008483
J Virol. 2008 Mar;82(5):2515-27
pubmed: 18094151
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5517-22
pubmed: 22431600
J Virol. 2012 Nov;86(21):11754-62
pubmed: 22915796
Biochemistry. 2022 Nov 15;61(22):2495-2505
pubmed: 36326185
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
J Med Chem. 2003 Sep 25;46(20):4265-72
pubmed: 13678405
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Sci Adv. 2023 Mar 29;9(13):eade8778
pubmed: 36989354
J Med Chem. 2022 Feb 24;65(4):2880-2904
pubmed: 34347470
mBio. 2022 Jun 28;13(3):e0078422
pubmed: 35471084
Sci Transl Med. 2023 Jan 11;15(678):eabq7360
pubmed: 36194133
J Chem Inf Model. 2020 Dec 28;60(12):6065-6073
pubmed: 33118813
Front Chem. 2022 Feb 24;10:852210
pubmed: 35281564
J Chem Inf Model. 2021 Sep 27;61(9):4331-4341
pubmed: 34467754
Antiviral Res. 2011 Nov;92(2):204-12
pubmed: 21854807
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
ACS Cent Sci. 2021 Oct 27;7(10):1638-1649
pubmed: 34729407
Science. 2021 Mar 26;371(6536):1374-1378
pubmed: 33602867
Nat Chem Biol. 2014 Dec;10(12):1066-72
pubmed: 25344815
Nat Chem Biol. 2011 Sep 18;7(11):769-78
pubmed: 21926995
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Cell Res. 2020 Aug;30(8):678-692
pubmed: 32541865
J Med Chem. 2022 Mar 10;65(5):4201-4217
pubmed: 35195401
Science. 2022 Sep 30;377(6614):eabn7065
pubmed: 36173843
Eur J Med Chem. 2021 Oct 15;222:113584
pubmed: 34118724
Nat Protoc. 2021 Oct;16(10):4799-4832
pubmed: 34561691
ACS Cent Sci. 2021 Mar 24;7(3):467-475
pubmed: 33786375
Cell. 2023 May 11;186(10):2160-2175.e17
pubmed: 37137306
Chem Biol. 2004 Oct;11(10):1445-53
pubmed: 15489171
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3058-62
pubmed: 15896959
J Med Chem. 2020 Nov 12;63(21):12542-12573
pubmed: 32930584
J Chem Inf Model. 2010 Sep 27;50(9):1561-73
pubmed: 20735049
Chem Biol. 2006 Mar;13(3):261-8
pubmed: 16638531
Int J Mol Sci. 2021 Oct 29;22(21):
pubmed: 34769210
J Med Chem. 2021 Apr 8;64(7):4109-4116
pubmed: 33761256
Cell Chem Biol. 2021 Dec 16;28(12):1795-1806.e5
pubmed: 34174194
ACS Med Chem Lett. 2021 Jul 14;12(8):1325-1332
pubmed: 34408808
J Med Chem. 2013 Jan 24;56(2):534-46
pubmed: 23231439
Nature. 2019 Feb;566(7743):224-229
pubmed: 30728502
J Med Chem. 2006 Aug 10;49(16):4971-80
pubmed: 16884309
ACS Med Chem Lett. 2022 Jul 19;13(8):1345-1350
pubmed: 35971455
Bioorg Chem. 2008 Oct;36(5):229-40
pubmed: 18295820
Nature. 2020 Mar;579(7800):609-614
pubmed: 32040955
Nature. 2021 Dec;600(7890):759-764
pubmed: 34880501
J Med Chem. 2021 Dec 9;64(23):17530-17539
pubmed: 34812616
Sci Adv. 2021 Apr 14;7(16):
pubmed: 33853786
Nature. 2019 Nov;575(7781):217-223
pubmed: 31666701
Biochemistry. 2007 Jul 31;46(30):8744-52
pubmed: 17605471
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2419-E2428
pubmed: 29453275
Nat Chem. 2020 Jul;12(7):581
pubmed: 32555379
Nature. 2018 Mar 8;555(7695):269-273
pubmed: 29466326
J Chem Inf Model. 2014 Feb 24;54(2):518-29
pubmed: 24410429
ACS Med Chem Lett. 2017 Jan 23;8(3):321-326
pubmed: 28337324
Chembiochem. 2023 Jun 1;24(11):e202300116
pubmed: 37069799
Nature. 2022 Oct;610(7932):582-591
pubmed: 36171289
Science. 2003 Jun 13;300(5626):1763-7
pubmed: 12746549
J Chem Inf Model. 2022 Jan 10;62(1):116-128
pubmed: 34793155
Nature. 2022 Jan;601(7893):452-459
pubmed: 34912117
J Med Chem. 2008 Apr 24;51(8):2502-11
pubmed: 18333608
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
SLAS Discov. 2022 Mar;27(2):79-85
pubmed: 35063690
J Med Chem. 2020 May 14;63(9):4562-4578
pubmed: 32045235
Trends Pharmacol Sci. 2012 May;33(5):289-94
pubmed: 22521415
Science. 2021 Dec 24;374(6575):1586-1593
pubmed: 34726479
Science. 2017 Oct 20;358(6361):381-386
pubmed: 29051383
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
pubmed: 21948594
PLoS One. 2013 Oct 01;8(10):e75992
pubmed: 24098414
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
Bioorg Med Chem Lett. 1998 Feb 17;8(4):333-8
pubmed: 9871680
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Bioorg Med Chem Lett. 2013 Nov 15;23(22):6172-7
pubmed: 24080461
Proc Natl Acad Sci U S A. 2023 Jan 10;120(2):e2212931120
pubmed: 36598939
ACS Cent Sci. 2023 Jul 24;9(8):1658-1669
pubmed: 37637734
mBio. 2023 Feb 28;14(1):e0281522
pubmed: 36625640
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Nature. 2015 Nov 26;527(7579):477-83
pubmed: 26550826
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5684-8
pubmed: 18796354
J Am Chem Soc. 2020 Mar 18;142(11):4960-4964
pubmed: 32105459
Nat Chem Biol. 2021 Feb;17(2):222-228
pubmed: 33093684
Nature. 2016 Sep 8;537(7619):185-190
pubmed: 27533032
J Chem Inf Model. 2015 Nov 23;55(11):2324-37
pubmed: 26479676
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Angew Chem Int Ed Engl. 2021 Apr 26;60(18):10423-10429
pubmed: 33655614
J Med Chem. 2016 Jul 28;59(14):6595-628
pubmed: 26878082
Elife. 2022 Jun 20;11:
pubmed: 35723575
Bioorg Med Chem. 2008 Apr 1;16(7):4138-49
pubmed: 18343121
Biophys J. 1998 Aug;75(2):769-76
pubmed: 9675178
J Am Chem Soc. 2022 Feb 23;144(7):2905-2920
pubmed: 35142215
ACS Catal. 2020;10:5871-5890
pubmed: 32391184
Nat Commun. 2022 Jun 21;13(1):3556
pubmed: 35729165
J Chem Inf Model. 2021 Feb 22;61(2):699-714
pubmed: 33494610
ChemMedChem. 2021 Mar 18;16(6):942-948
pubmed: 33283984
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
pubmed: 6035483
Protein Sci. 2023 Aug;32(8):e4712
pubmed: 37354015
J Virol. 2005 Jun;79(11):7095-103
pubmed: 15890949
Nat Commun. 2020 Oct 7;11(1):5047
pubmed: 33028810
Sci Transl Med. 2020 Aug 19;12(557):
pubmed: 32747425
J Med Chem. 2022 May 12;65(9):6499-6512
pubmed: 35352927

Auteurs

Elissa A Fink (EA)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
Graduate Program in Biophysics, University of California-San Francisco, San Francisco, California, USA.

Conner Bardine (C)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
Graduate Program in Chemistry and Chemical Biology, University of California-San Francisco, San Francisco, California, USA.

Stefan Gahbauer (S)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Isha Singh (I)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Tyler C Detomasi (TC)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Kris White (K)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Shuo Gu (S)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Xiaobo Wan (X)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Jun Chen (J)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Beatrice Ary (B)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Isabella Glenn (I)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Joseph O'Connell (J)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Henry O'Donnell (H)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Pavla Fajtová (P)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, San Diego, California, USA.

Jiankun Lyu (J)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Seth Vigneron (S)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Nicholas J Young (NJ)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Ivan S Kondratov (IS)

Enamine Ltd., Kyïv, Ukraine.
V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Kyïv, Ukraine.

Arghavan Alisoltani (A)

Division of Infectious Diseases, Center for Pathogen Genomics and Microbial Evolution, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Lacy M Simons (LM)

Division of Infectious Diseases, Center for Pathogen Genomics and Microbial Evolution, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Ramon Lorenzo-Redondo (R)

Division of Infectious Diseases, Center for Pathogen Genomics and Microbial Evolution, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Egon A Ozer (EA)

Division of Infectious Diseases, Center for Pathogen Genomics and Microbial Evolution, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Judd F Hultquist (JF)

Division of Infectious Diseases, Center for Pathogen Genomics and Microbial Evolution, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Anthony J O'Donoghue (AJ)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, San Diego, California, USA.

Yurii S Moroz (YS)

National Taras Shevchenko University of Kyïv, Kyïv, Ukraine.
Chemspace LLC, Kyïv, Ukraine.

Jack Taunton (J)

Department of Cellular and Molecular Pharmacology, University of California-San Francisco, San Francisco, California, USA.

Adam R Renslo (AR)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

John J Irwin (JJ)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
QBI COVID-19 Research Group (QCRG), San Francisco, California, USA.

Brian K Shoichet (BK)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
QBI COVID-19 Research Group (QCRG), San Francisco, California, USA.

Charles S Craik (CS)

Department of Pharmaceutical Chemistry, University of California-San Francisco, San Francisco, California, USA.
QBI COVID-19 Research Group (QCRG), San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH